• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
ACR Appropriateness Criteria external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II.美国放射学会（ACR）适切性标准：临床局限性前列腺癌的外照射放疗治疗计划，共两部分，此为第一部分
Adv Radiat Oncol. 2016 Oct 20;2(1):62-84. doi: 10.1016/j.adro.2016.10.002. eCollection 2017 Jan-Mar.
2
ACR Appropriateness Criteria® definitive external beam irradiation in stage T1 and T2 prostate cancer.ACR 适宜性标准® T1 和 T2 期前列腺癌的明确体外放射治疗。
Am J Clin Oncol. 2011 Dec;34(6):636-47. doi: 10.1097/COC.0b013e3182354a65.
3
ACR appropriateness criteria on external beam radiation therapy treatment planning for clinically localized prostate cancer expert panel on radiation oncology--prostate.美国放射学会（ACR）关于临床局限性前列腺癌外照射放疗治疗计划的适宜性标准——放射肿瘤学专家小组——前列腺癌
Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):667-72. doi: 10.1016/j.ijrobp.2008.12.073. Epub 2009 Apr 20.
4
ACR appropriateness criteria: Permanent source brachytherapy for prostate cancer.美国放射学会适宜性标准：前列腺癌永久性源近距离放射治疗
Brachytherapy. 2017 Mar-Apr;16(2):266-276. doi: 10.1016/j.brachy.2016.10.002. Epub 2016 Dec 7.
5
Is brachytherapy comparable with radical prostatectomy and external-beam radiation for clinically localized prostate cancer?对于临床局限性前列腺癌，近距离放射治疗与根治性前列腺切除术及外照射放疗相比效果如何？
Tech Urol. 2001 Mar;7(1):12-9.
6
Treatment planning for clinically localized prostate cancer. American College of Radiology. ACR Appropriateness Criteria.临床局限性前列腺癌的治疗规划。美国放射学会。ACR适宜性标准。
Radiology. 2000 Jun;215 Suppl:1441-8.
7
Comparing prostate specific antigen outcomes after different types of radiotherapy management of clinically localized prostate cancer highlights the importance of controlling for established prognostic factors.比较临床局限性前列腺癌不同放疗管理方式后的前列腺特异性抗原结果，凸显了控制既定预后因素的重要性。
J Urol. 2000 Jun;163(6):1797-801.
8
Prediagnosis prostate specific antigen velocity is associated with risk of prostate cancer progression following brachytherapy and external beam radiation therapy.诊断前前列腺特异性抗原速度与近距离放射治疗和外照射放疗后前列腺癌进展风险相关。
J Urol. 2006 Oct;176(4 Pt 1):1399-403. doi: 10.1016/j.juro.2006.06.045.
9
Salvage prostate brachytherapy for localized prostate cancer failure after external beam radiation therapy.挽救性前列腺近距离放射治疗用于外照射放疗后局部前列腺癌复发
Brachytherapy. 2008 Jan-Mar;7(1):17-21. doi: 10.1016/j.brachy.2007.11.002. Epub 2008 Jan 16.
10
Definitive external beam irradiation in stage T1 and T2 carcinoma of the prostate. American College of Radiology. ACR Appropriateness Criteria.前列腺T1和T2期癌的确定性外照射放疗。美国放射学会。ACR适宜性标准。
Radiology. 2000 Jun;215 Suppl:1449-72.

引用本文的文献

1
Stereotactic Body Radiation Therapy for Clinically Localized Prostate Cancer in Men With Hip Prostheses: A Cautionary Note.立体定向体部放射治疗用于患有髋关节假体的男性临床局限性前列腺癌：一则警示
Cureus. 2024 May 31;16(5):e61432. doi: 10.7759/cureus.61432. eCollection 2024 May.
2
Bowel and Bladder Reproducibility in Image Guided Radiation Therapy for Prostate Cancer: Results of a Patterns of Practice Survey.前列腺癌图像引导放射治疗中肠道和膀胱的可重复性：实践模式调查结果
Adv Radiat Oncol. 2022 Feb 3;7(5):100902. doi: 10.1016/j.adro.2022.100902. eCollection 2022 Sep-Oct.
3
Assessing Inter-Fraction Changes in The Size and Position of The Penile Bulb During Daily MR-Guided Radiation Therapy to The Prostate Bed: Do We Need to Adjust How We Plan Radiation in The Post-Radical Prostatectomy Setting to Reduce Risk of Erectile Dysfunction?评估每日 MR 引导前列腺床放射治疗期间阴茎球部大小和位置的分次变化：我们是否需要调整放射治疗计划以降低前列腺根治术后勃起功能障碍的风险？
Clin Genitourin Cancer. 2022 Jun;20(3):e227-e232. doi: 10.1016/j.clgc.2022.01.006. Epub 2022 Jan 11.
4
Salvage therapy for prostate cancer after radical prostatectomy.根治性前列腺切除术后的前列腺癌挽救治疗。
Nat Rev Urol. 2021 Nov;18(11):643-668. doi: 10.1038/s41585-021-00497-7. Epub 2021 Aug 6.
5
Clinical and radiobiological evaluation of a method for planning target volume generation dependent on organ-at-risk exclusions in magnetic resonance imaging-based prostate radiotherapy.基于磁共振成像的前列腺放疗中一种依赖危及器官排除的计划靶区生成方法的临床和放射生物学评估
Phys Imaging Radiat Oncol. 2018 Dec 7;8:51-56. doi: 10.1016/j.phro.2018.11.007. eCollection 2018 Oct.
6
MRI-Based Proton Treatment Planning for Base of Skull Tumors.基于MRI的颅底肿瘤质子治疗计划
Int J Part Ther. 2019 Fall;6(2):12-25. doi: 10.14338/IJPT-19-00062.1. Epub 2019 Sep 30.
7
Late toxicity after post-prostatectomy intensity modulated radiation therapy: Evaluating normal-tissue sparing guidelines.前列腺切除术后调强放射治疗的晚期毒性：评估正常组织保护指南。
Adv Radiat Oncol. 2018 May 8;3(3):339-345. doi: 10.1016/j.adro.2018.04.009. eCollection 2018 Jul-Sep.
8
Intensity-modulated radiotherapy for prostate cancer.前列腺癌的调强放射治疗
Transl Androl Urol. 2018 Jun;7(3):297-307. doi: 10.21037/tau.2017.12.16.
9
Comparison of Image-Guided Intensity-Modulated Radiotherapy and Low-dose Rate Brachytherapy with or without External Beam Radiotherapy in Patients with Localized Prostate Cancer.局部前列腺癌患者的图像引导调强放疗与低剂量率近距离放疗联合或不联合外照射放疗的比较。
Sci Rep. 2018 Jul 12;8(1):10538. doi: 10.1038/s41598-018-28730-1.
10
The evolution of brachytherapy for prostate cancer.前列腺癌近距离治疗的演变。
Nat Rev Urol. 2017 Jun 30;14(7):415-439. doi: 10.1038/nrurol.2017.76.

本文引用的文献

1
Impact of obesity on outcomes after definitive dose-escalated intensity-modulated radiotherapy for localized prostate cancer.肥胖对局限性前列腺癌确定性剂量递增调强放疗后结局的影响。
Cancer. 2015 Sep 1;121(17):3010-7. doi: 10.1002/cncr.29472. Epub 2015 May 29.
2
Anterior-oriented proton beams for prostate cancer: A multi-institutional experience.用于前列腺癌的前向质子束：多机构经验
Acta Oncol. 2015 Jun;54(6):868-74. doi: 10.3109/0284186X.2014.986288. Epub 2015 Jan 16.
3
Cancer statistics, 2015.癌症统计数据，2015 年。
CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29. doi: 10.3322/caac.21254. Epub 2015 Jan 5.
4
ACR appropriateness Criteria® Postradical prostatectomy irradiation in prostate cancer.ACR 适宜性标准®前列腺癌根治术后放疗。
Oncology (Williston Park). 2014 Dec;28(12):1125-30, 1132-6.
5
Stereotactic Body Radiation Therapy for Prostate Cancer: Review of Experience of a Multicenter Phase I/II Dose-Escalation Study.立体定向体部放射治疗前列腺癌：多中心 I/II 期剂量递增研究经验综述
Front Oncol. 2014 Nov 26;4:319. doi: 10.3389/fonc.2014.00319. eCollection 2014.
6
Evaluating toxicity from definitive radiation therapy for prostate cancer in men with inflammatory bowel disease: Patient selection and dosimetric parameters with modern treatment techniques.评估炎症性肠病男性患者接受前列腺癌根治性放射治疗的毒性：现代治疗技术下的患者选择和剂量学参数
Pract Radiat Oncol. 2015 May-Jun;5(3):e215-e222. doi: 10.1016/j.prro.2014.09.004. Epub 2014 Oct 30.
7
Effect of metal hip prosthesis on the accuracy of electromagnetic localization tracking.金属髋关节假体对电磁定位跟踪准确性的影响。
Pract Radiat Oncol. 2015 Jan-Feb;5(1):43-8. doi: 10.1016/j.prro.2014.03.010. Epub 2014 May 14.
8
Stereotactic ultrasound for target volume definition in a patient with prostate cancer and bilateral total hip replacement.立体定向超声在一名患有前列腺癌且双侧全髋关节置换患者中用于靶区定义
Pract Radiat Oncol. 2015 May-Jun;5(3):197-202. doi: 10.1016/j.prro.2014.08.008. Epub 2014 Sep 26.
9
Local recurrence map to guide target volume delineation after radical prostatectomy.局部复发图谱用于指导前列腺癌根治术后靶区勾画。
Pract Radiat Oncol. 2014 Nov-Dec;4(6):e239-46. doi: 10.1016/j.prro.2014.02.007. Epub 2014 Apr 16.
10
Quality of Life and Toxicity after SBRT for Organ-Confined Prostate Cancer, a 7-Year Study.SBRT 治疗局限性前列腺癌 7 年的生活质量和毒性研究。
Front Oncol. 2014 Oct 28;4:301. doi: 10.3389/fonc.2014.00301. eCollection 2014.

ACR Appropriateness Criteria external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II.

作者信息

Zaorsky Nicholas G, Showalter Timothy N, Ezzell Gary A, Nguyen Paul L, Assimos Dean G, D'Amico Anthony V, Gottschalk Alexander R, Gustafson Gary S, Keole Sameer R, Liauw Stanley L, Lloyd Shane, McLaughlin Patrick W, Movsas Benjamin, Prestidge Bradley R, Taira Al V, Vapiwala Neha, Davis Brian J

机构信息

Fox Chase Cancer Center, Philadelphia, Pennsylvania (research author).

University of Virginia, Charlottesville, Virginia (principal author).

出版信息

Adv Radiat Oncol. 2016 Oct 20;2(1):62-84. doi: 10.1016/j.adro.2016.10.002. eCollection 2017 Jan-Mar.

DOI:10.1016/j.adro.2016.10.002
PMID:28740916
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5514238/
Abstract
摘要